# VIGABATRIN
> **ANDA209822** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-01-14
## Drug
- **FDA Application Number:** ANDA209822
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VIGABATRIN
- **Generic name:** VIGABATRIN
- **Active ingredients:** VIGABATRIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2019-01-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209822)
---
*AI Analytics · CC0 1.0*